
Immune therapy eliminates tumour cells in early triple negative breast cancer
Immune therapy added to chemotherapy improves pathological complete response in patients with early triple negative breast cancer, according to late breaking results from the KEYNOTE-522 trial presented at the ESMO Congress ...
Sep 29, 2019
0
4